Infinity stores ‘continue to trade well’: Wesfarmers Health
The health arm of the conglomerate gave an update on the 73 Infinity Group Priceline Pharmacies, as the division zooms in on its format, ranges and loyalty program Wesfarmers Health …
‘More stores, more productive stores’: Sigma’s pipeline outlined
The CWH owner lifted full-year earnings on the back of the GLP-1 boom and detailed plans for upcoming stores openings and UK expansion Wholesaler Sigma Healthcare has posted a 22% …
World news wrapup: 27 August 2026
Pharmacy tourism in Paris; Nashville medication mix-up results in patient paralysis; GLP-1 pill hits the UK market Paris, France: Forget the Eiffel Tower and the Lourve. The Times reports that …
Suspended doc ‘wrote 147 scripts’: Ahpra
A pharmacy complaint sparked the professional regulator investigation, which revealed the doctor had prescribed restricted medicines to patients while suspended, Ahpra says A Western Australian doctor worked for four months …
Pharmacists fined for alleged unlawful melatonin imports
Both a company and individual pharmacists received infringement notices after allegedly bringing in unlawful melatonin products, the TGA says Three registered pharmacists and a Queensland-based company have received fines totalling …
GLP-1 gains boost EBOS’ bottom line
The wholesaler and marketer indicated demand for high-value medicines has helped to offset headwinds from rising fuel costs Diversified company EBOS says network expansion and glucagon-like peptide-1 receptor agonists (GLP-1s) …
‘Unusual’ for GLP-1 to not be listed: Lilly boss
The world’s largest pharmaceutical company said its weight loss and diabetes medicine belongs on the PBS at “a fair price”, as health minister indicates negotiations with companies will continue Discussions …
Scope for MS meds rapid review detailed
The health department and PBS have released guidance on the review of medicines for relapsing-remitting multiple sclerosis following recommendations from a recent PBAC meeting The Department of Health, Disability and …
‘We’re seeing some really significant issues’
Unregulated peptides are causing increasing concern for regulators, with serious side effects, unknown ingredients and a lack of sterility among the issues they are grappling with. Healthcare professionals have a …
‘Approaching profitability’: StrongRoom secures banner group investors
The revived pharmatech says it’s collected new capital from across the market in its bid to expand further into AI and workflow automation StrongRoom AI’s recent transformation has put it …
THC exposure landing more children in hospital
A poisons line has seen a steady increase in calls for paediatric exposures to cannabis compounds Poisons information services have seen a rise in children accidentally exposed to THC (tetrahydrocannabinol), …
Flow state: making your pharmacy set up work for your goals
Pharmacies and workflows are increasingly being redesigned to support full scope, but the task itself isn’t always straightforward. Kate Cowling looks at the key considerations from those who have embarked …